Frazier Management LLC
- SEC CIK
- 0001032165
- 最新申報
- 2022/11/14
2022 年第 1 季持倉
持倉截至 2022/3/31，2022/5/13 申報。只含多頭部位，變化是跟 2021 年第 4 季比股數。
- 持股檔數
- 2
- 較 2021 年第 4 季 −41
- 總值
- $198.8 萬
- 較 2021 年第 4 季 −$13.0 億 (−99.8%)
2021 年第 4 季之後清倉（41 檔）
2021 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2021 年第 4 季股數 | 2021 年第 4 季市值 | 2021 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ARQTArcutis Biotherapeutics, Inc. | COM | 8,434,232 | $1.75 億 | 13.5% | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 5,827,415 | $1.15 億 | 8.8% | 歷史 |
| IMGOImago BioSciences, Inc. | COM | 2,971,274 | $7,045 萬 | 5.4% | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,772,062 | $6,068 萬 | 4.7% | 歷史 |
| GRTSGritstone bio, Inc. | COM | 4,667,242 | $6,002 萬 | 4.6% | 歷史 |
| MIRMMirum Pharmaceuticals, Inc. | COM | 3,566,912 | $5,689 萬 | 4.4% | 歷史 |
| PCVXVaxcyte, Inc. | COM | 2,309,554 | $5,494 萬 | 4.2% | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 771,250 | $5,395 萬 | 4.2% | 歷史 |
| PRDSPardes Biosciences, Inc. | COM | 2,457,507 | $4,023 萬 | 3.1% | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 1,384,293 | $3,933 萬 | 3.0% | 歷史 |
| KDNYChinook Therapeutics, Inc. | COM | 2,371,918 | $3,869 萬 | 3.0% | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 555,240 | $3,380 萬 | 2.6% | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,747,622 | $3,336 萬 | 2.6% | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,417,157 | $3,189 萬 | 2.5% | 歷史 |
| PASGPassage BIO, Inc. | COM | 5,009,219 | $3,181 萬 | 2.4% | 歷史 |
| ANABAnaptysbio, Inc | COM | 899,700 | $3,127 萬 | 2.4% | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 1,838,402 | $3,074 萬 | 2.4% | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 1,505,200 | $2,976 萬 | 2.3% | 歷史 |
| STROSutro Biopharma, Inc. | COM | 1,776,479 | $2,643 萬 | 2.0% | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,784,913 | $2,472 萬 | 1.9% | 歷史 |
| SLNSilence Therapeutics plc | ADS | 886,173 | $2,117 萬 | 1.6% | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 3,746,857 | $1,945 萬 | 1.5% | 歷史 |
| MRUSMerus N.V. | COM | 559,179 | $1,778 萬 | 1.4% | 歷史 |
| REPLReplimune Group, Inc. | COM | 650,862 | $1,764 萬 | 1.4% | 歷史 |
| TYRATyra Biosciences, Inc. | COM | 1,250,000 | $1,759 萬 | 1.4% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 1,305,087 | $1,727 萬 | 1.3% | 歷史 |
| TCDATricida, Inc. | COM | 1,783,893 | $1,705 萬 | 1.3% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,774,891 | $1,523 萬 | 1.2% | 歷史 |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 1,501,000 | $1,489 萬 | 1.1% | – |
| ARVNArvinas, Inc. | COM | 163,763 | $1,345 萬 | 1.0% | 歷史 |
| Gracell Biotechnologies Inc38406L103 | SPONSORED ADS | 1,654,938 | $999.6 萬 | 0.8% | – |
| EPIXESSA Pharma Inc. | COM NEW | 543,470 | $771.7 萬 | 0.6% | 歷史 |
| RGNXREGENXBIO Inc. | COM | 235,809 | $771.1 萬 | 0.6% | 歷史 |
| AVDLAvadel Pharmaceuticals PLC | SPONSORED ADR | 951,814 | $769.1 萬 | 0.6% | 歷史 |
| ACRSAclaris Therapeutics, Inc. | COM | 408,329 | $593.7 萬 | 0.5% | 歷史 |
| MTEMMolecular Templates, Inc. | COM | 1,374,047 | $538.6 萬 | 0.4% | 歷史 |
| APTXAptinyx Inc. | COM | 1,883,244 | $502.8 萬 | 0.4% | 歷史 |
| IMVTImmunovant, Inc. | COM | 585,759 | $499.1 萬 | 0.4% | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 156,000 | $387.5 萬 | 0.3% | 歷史 |
| EPZMEpizyme, Inc. | COM | 739,369 | $184.8 萬 | 0.1% | 歷史 |
| Nabriva Therapeutics plcG63637113 | SHS | 425,650 | $25.5 萬 | <0.1% | – |